|
311 |
Performance of the nonstructural 1 Antigen Rapid Test for detecting all four DENV serotypes in clinical specimens from Bangkok, Thailand
Enthalten in Virology journal Bd. 19, 27.10.2022, Nr. 1, date:12.2022: 1-6
|
|
|
|
312 |
Performance of urine DNA Neuritin 1 methylation test for urothelial carcinoma detection
Enthalten in Molecular biomedicine Bd. 6, 8.2.2025, Nr. 1, date:12.2025: 1-4
|
|
|
|
313 |
Platelet factor 3 availability test: an effective screening test for types 1 and 2 von Willebrand disease
Enthalten in Annals of hematology Bd. 83, 30.3.2004, Nr. 7, date:7.2004: 489-490
|
|
|
|
314 |
Ppe.RPT/SSC-1: from QTL mapping to a predictive KASP test for ripening time and soluble solids concentration in peach
Enthalten in Scientific reports Bd. 14, 17.1.2024, Nr. 1, date:12.2024: 1-13
|
|
|
|
315 |
Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of Type 1 (insulin-dependent) diabetic patients
Enthalten in Diabetologia Bd. 34, 1.8.1991, Nr. 2, date:2.1991: 93-102
|
|
|
|
316 |
Properties of permutation-based gene tests and controlling type 1 error using a summary statistic based gene test
Enthalten in BMC genetics Bd. 14, 7.11.2013, Nr. 1, date:12.2013: 1-12
|
|
|
|
317 |
Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations
Enthalten in Journal for ImmunoTherapy of Cancer Bd. 7, 29.3.2019, Nr. 1, date:12.2019: 1-8
|
|
|
|
318 |
Quadriceps physiological response during the 1-min sit-to-stand test in people with severe COPD and healthy controls
Enthalten in Scientific reports Bd. 12, 17.1.2022, Nr. 1, date:12.2022: 1-10
|
|
|
|
319 |
Randomized double-blind personalized N-of-1 clinical trial to test the safety and potential efficacy of TJ-68 for treating muscle cramps in amyotrophic lateral sclerosis (ALS): study protocol for a TJ-68 trial
Enthalten in Trials Bd. 24, 10.7.2023, Nr. 1, date:12.2023: 1-17
|
|
|
|
320 |
Real-World Effectiveness of Dolutegravir/Lamivudine in People With HIV-1 in Test-and-Treat Settings or With High Baseline Viral Loads: TANDEM Study Subgroup Analyses
Enthalten in Infectious diseases and therapy Bd. 13, 3.4.2024, Nr. 4, date:4.2024: 875-889
|
|
Administration
